GUTS Fractyl Health, Inc. Common Stock
Healthcare$0.92+0.90%ClosedMarket Cap: $66.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.23
P/S
0.00
EV/EBITDA
-0.69
DCF Value
$0.24
FCF Yield
-133.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-4573.9%
ROA
-108.7%
ROIC
-104.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-20.8M | $9.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-23.3M | $-43.7M | $— | — |
| FY null | $0.00 | NaN% | $-96.8M | $-141.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-22.7M | $-45.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-26.1M | $-27.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-24.8M | $-23.7M | $— | — |
| Q4 null | $3.0K | 100.0% | $-25.2M | $-25.0M | $— | — |
| FY null | $93.0K | 46.2% | $-93.5M | $-68.7M | $— | — |
| Q3 null | $14.0K | 50.0% | $-23.8M | $-23.2M | $— | — |
| Q2 null | $43.0K | 44.2% | $-23.0M | $-17.2M | $— | — |
| Q1 null | $33.0K | 42.4% | $-21.5M | $-3.3M | $— | — |
| Q4 2023 | $7.0K | 71.4% | $-13.0M | $-19.2M | $-0.40 | — |